t
Benchmark Holdings plc announced that all resolutions were passed by shareholders at its Annual General Meeting, held on 8 February 2024 at 12:00 midday. Shareholders cast votes representing 87.31% of the Company's Issued Share Capital, with individual resolutions receiving between 94.94% and 100.00% of votes "for".
| Date | 8 Feb 2024 |
| Time | 16:00:00 |
| Category | AGMs and other meetings |
| ID | 5449C |
8 February 2024
Benchmark Holdings plc
("Benchmark" or the "Company")
Result of AGM
Benchmark Holdings plc, the aquaculture health, nutrition and genetics business, announces that at the Company's Annual General Meeting, held at 12.00 midday today, all resolutions were passed by shareholders voting on a poll. The results of the poll are set out below.
|
|
RESOLUTION NAME |
VOTES |
% |
VOTES |
% |
VOTES |
% of ISC VOTED |
VOTES |
|
1 |
Report and accounts |
645,672,343 |
100.00 |
0 |
0.00 |
645,672,343 |
87.31% |
0 |
|
2 |
Remuneration Report |
612,982,715 |
94.94 |
32,689,628 |
5.06 |
645,672,343 |
87.31% |
0 |
|
3 |
Reappoint Auditors |
643,743,477 |
99.70 |
1,928,866 |
0.30 |
645,672,343 |
87.31% |
0 |
|
4 |
Auditors remuneration |
645,610,137 |
99.99 |
58,456 |
0.01 |
645,668,593 |
87.31% |
3,750 |
|
5 |
Trond Williksen |
645,606,455 |
99.99 |
65,888 |
0.01 |
645,672,343 |
87.31% |
0 |
|
6 |
Kristian Eikre |
613,627,401 |
95.04 |
32,044,942 |
4.96 |
645,672,343 |
87.31% |
0 |
|
7 |
Septima Maguire |
645,623,216 |
99.99 |
49,127 |
0.01 |
645,672,343 |
87.31% |
0 |
|
8 |
Peter George |
622,043,212 |
96.34 |
23,629,131 |
3.66 |
645,672,343 |
87.31% |
0 |
|
9 |
Yngve Myhre |
645,611,387 |
99.99 |
60,956 |
0.01 |
645,672,343 |
87.31% |
0 |
|
10 |
Jonathan Esfandi |
643,783,409 |
99.71 |
1,888,934 |
0.29 |
645,672,343 |
87.31% |
0 |
|
11 |
Torgeir Svae |
643,780,909 |
99.71 |
1,891,434 |
0.29 |
645,672,343 |
87.31% |
0 |
|
12 |
Marie Danielsson |
643,783,409 |
99.71 |
1,888,934 |
0.29 |
645,672,343 |
87.31% |
0 |
|
13 |
Allot shares |
624,578,624 |
96.73 |
21,081,451 |
3.27 |
645,660,075 |
87.31% |
12,268 |
|
14 |
Disapply pre-emption rights |
645,600,998 |
99.99 |
59,077 |
0.01 |
645,660,075 |
87.31% |
12,268 |
|
15 |
Disapply additional pre-emption rights |
643,739,328 |
99.70 |
1,920,747 |
0.30 |
645,660,075 |
87.31% |
12,268 |
|
16 |
Purchase own shares |
643,743,231 |
99.70 |
1,929,112 |
0.30 |
645,672,343 |
87.31% |
0 |
Enquiries
|
|
About Benchmark
Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering mission-critical products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare. Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all the aquaculture regions around the world.
Find out more at www.benchmarkplc.com